BPC 157 5/10mg
(NOT FOR HUMAN CONSUMPTION RESEARCH USE ONLY)
PBC 157
is likely a typographical error for the peptide BPC 157(Body Protective Compound 157), a synthetic peptide extensively researched for its potent regenerative and anti-inflammatory properties, particularly in animal models of tissue injury. It is not approved for human medical use by any regulatory body and is banned in professional sports.
Function and Mechanism
BPC 157 is a 15-amino-acid peptide derived from a naturally occurring protein in human gastric juice. It works through multiple pathways to promote healing throughout the body, from the gut to muscles, tendons, and even nerves.
- Angiogenesis: A key mechanism is stimulating the formation of new blood vessels, a process called angiogenesis, by activating the VEGFR2 (Vascular Endothelial Growth Factor Receptor 2) pathway. This improves blood flow and delivers essential nutrients to injured areas.
- Tissue Regeneration: It enhances the expression of growth hormone receptors and influences cell migration, proliferation, and survival (through pathways like FAK-paxillin and ERK1/2), accelerating the repair of various tissues, including muscles, tendons, ligaments, and bones.
- Anti-Inflammatory Effects: BPC 157 significantly reduces pro-inflammatory cytokines like TNF-α and IL-6, helping to modulate the immune response and alleviate pain and swelling associated with injury or chronic conditions like inflammatory bowel disease.
- Neuroprotection: Studies suggest it has neuroprotective properties, aiding in the recovery from traumatic brain injury, spinal cord compression, and peripheral nerve damage in animal models.
Regulatory Status and Safety
Despite promising results in animal studies, BPC 157 remains an investigational compound with limited human clinical data.
- FDA Status: BPC 157 is not an FDA-approved drug for any human use. The FDA has listed it as a substance that raises significant safety concerns and is ineligible for use in compounded medications.
- WADA Status: It is a prohibited substance under the S0 Non-Approved Substances category of the World Anti-Doping Agency's (WADA) Prohibited List. Athletes using BPC 157 can face disqualification.